Carrie S. Cox
Chairman
Organon & Co. (OGN)Board Member
Organon & Co. (OGN)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Carrie S. Cox
Carrie S. Cox is recorded as Chairman and Board Member at Organon & Co. (OGN). Organon & Co. reported in an 8-K filed April 27, 2026 that Carrie S. Cox was appointed Executive Chair, effective April 26, 2026. Organon & Co. reported in an 8-K filed October 27, 2025 that Carrie S. Cox was appointed Executive Chair for an interim period, effective October 26, 2025.
“On April 26, 2026, Ms. Cox was appointed to serve as Executive Chair on a non-interim basis.”
“On October 26, 2025, Carrie S. Cox, Chair of the Board, was appointed Executive Chair for an interim period.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-10-26–present
-
Current
2021-06-02–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Organon & Co.
Other people whose current roles at this company are on record from its filings.
- Joseph Morrissey CEO
- Kevin Ali CEO
- Matthew Walsh CFO
- Rachel Stahler CIO
- Kirke Weaver General Counsel
- Alan Ezekowitz, M.D., Ph.D. Board Member
- Cynthia M. Patton Board Member
- Deborah Leone Board Member
- Deborah R. Leone Board Member
- Grace Puma Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.